Abatacept

Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

Treatment Tapering in JIA With Inactive Disease

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Abatacept for the Treatment of Giant Cell Arteritis

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Abatacept as GVHD Prophylaxis Phase 2

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

Abatacept Conversion in Kidney Transplantation

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis